Arrowhead Pharmaceuticals Inc. buy HC Wainwright
Start price
08.02.24
/
50%
€28.61
Target price
08.02.25
€83.48
Performance (%)
-19.54%
Price
16.05.24
€23.02
Summary
This prediction is currently active. The prediction for Arrowhead Pharmaceuticals Inc. disappoints with a performance of -19.54%. This prediction currently runs until 08.02.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -1.876% | -1.876% |
iShares Core DAX® | -0.051% | 4.829% |
iShares Nasdaq 100 | 1.659% | 2.417% |
iShares Nikkei 225® | 0.658% | -2.173% |
iShares S&P 500 | 0.964% | 2.547% |
Comments by HC_Wainwright for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by HC_Wainwright for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.12
13.05.24
13.05.24
€83.32
13.05.25
13.05.25
14.41%
16.05.24
16.05.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.39
10.08.23
10.08.23
€81.59
10.08.24
10.08.24
-12.77%
16.05.24
16.05.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€30.89
13.07.23
13.07.23
€80.49
13.07.24
13.07.24
-25.51%
16.05.24
16.05.24